HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Restriction Proposal Targets 4.4M Tons Of PFAS Headed For Environment Over Next 30 Years

Executive Summary

“While the evaluation of such a broad proposal with thousands of substances, and many uses, will be challenging, we are ready,” says ECHA director for risk assessment Peter van der Zandt. Prepared by authorities in Denmark, Germany, the Netherlands, Norway and Sweden, the restriction proposal has been handed over to ECHA’s scientific committees.

You may also be interested in...



L’Oreal USA Dismisses Suit Alleging Deceptive Marketing Of PFAS-Containing Mascaras

The US District Court for the Southern District of New York grants L’Oréal USA’s motion to dismiss a putative class action in which plaintiffs say they would not have purchased or paid a premium price for the firm’s waterproof mascaras had they known of the presence of PFAS. According to the judge, the amended complaint lacks crucial evidence even at the pleading stage.

ECHA Committees Get Started On PFAS Opinions, Armed With More Than 5,600 Comments

The agency’s committees for Risk Assessment and Socio-Economic Analysis will check comments and take relevant evidence-based information into consideration as they develop their opinions. Final opinions will be delivered to the European Commission “in the shortest possible timeframe,” ECHA says.

EU Cosmetics, Pharma Industries Expected To Pick Up Tab For Micropollutants Under Proposed UWWTD Recast

Cosmetics Europe says the European Commission’s proposed recast of the Urban Wastewater Treatment Directive places responsibility for micro-pollutants in urban wastewater squarely on the cosmetics and pharmaceuticals industries, ignoring other sources. The proposal would require Member States to provide for extended producer responsibility (EPR) systems to fund upgrades to wastewater treatment plants and administrative costs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel